UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 49

Sortiert nach

Detection rates and phenotypic spectrum of m.3243A>G in the MT-TL1 gene: a molecular diagnostic laboratory perspective

Mitochondrion, 2014-07, Vol.17, p.34-41

2014

Volltextzugriff (PDF)

A Molecular Framework for the Phylogeny of the Ant Subfamily Dolichoderinae

Molecular phylogenetics and evolution, 2000-10, Vol.17 (1), p.108-116

2000

Volltextzugriff (PDF)

Molecular Evidence for a Jurassic Origin of Ants

Die Naturwissenschaften, 1997-01, Vol.84 (1), p.22-23

1997

Volltextzugriff (PDF)

Functional respiratory chain analyses in murid xenomitochondrial cybrids expose coevolutionary constraints of cytochrome b and nuclear subunits of complex III

Molecular biology and evolution, 2003-07, Vol.20 (7), p.1117-1124

2003

Volltextzugriff (PDF)

Role of Anthropometric Characteristics in Idiopathic Carpal Tunnel Syndrome

Archives of physical medicine and rehabilitation, 2013-04, Vol.94 (4), p.737-744

2013

Volltextzugriff (PDF)

P.P.6 04 The clinical and molecular characterisation of calpain deficiency in patients with neuromuscular disorders

Neuromuscular disorders : NMD, 2006-10, Vol.16 (9), p.695-695

2006

Volltextzugriff (PDF)

Alzheimer's disease profiled by fluid and imaging markers: tau PET best predicts cognitive decline

Molecular psychiatry, 2021-10, Vol.26 (10), p.5888-5898

2021

Volltextzugriff (PDF)

Diverging longitudinal changes in astrocytosis and amyloid PET in autosomal dominant Alzheimer's disease

Brain (London, England : 1878), 2016-03, Vol.139 (Pt 3), p.922-936

2016

Volltextzugriff (PDF)

Longitudinal changes of tau PET imaging in relation to hypometabolism in prodromal and Alzheimer’s disease dementia

Molecular psychiatry, 2017-05, Vol.23 (7), p.1666-1673

2017

Volltextzugriff (PDF)

The strategic biomarker roadmap for the validation of Alzheimer’s diagnostic biomarkers: methodological update

European journal of nuclear medicine and molecular imaging, 2021-07, Vol.48 (7), p.2070-2085

2021

Volltextzugriff (PDF)

Profiling of plasma biomarkers in the context of memory assessment in a tertiary memory clinic

Translational psychiatry, 2023-07, Vol.13 (1), p.268-268, Article 268

2023

Volltextzugriff (PDF)

Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers

Lancet neurology, 2017-08, Vol.16 (8), p.661-676

2017

Volltextzugriff (PDF)

Clinical validity of increased cortical uptake of amyloid ligands on PET as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework

Neurobiology of aging, 2017-04, Vol.52, p.214-227

2017

Volltextzugriff (PDF)

Comparison of Early-Phase 11C-Deuterium-l-Deprenyl and 11C-Pittsburgh Compound B PET for Assessing Brain Perfusion in Alzheimer Disease

The Journal of nuclear medicine (1978), 2016-07, Vol.57 (7), p.1071-1077

2016

Volltextzugriff (PDF)

Clinical validity of increased cortical binding of tau ligands of the THK family and PBB3 on PET as biomarkers for Alzheimer’s disease in the context of a structured 5-phase development framework

European journal of nuclear medicine and molecular imaging, 2021-07, Vol.48 (7), p.2086-2096

2021

Volltextzugriff (PDF)

Blood β-synuclein is related to amyloid PET positivity in memory clinic patients

Alzheimer's & dementia, 2023-11, Vol.19 (11), p.4896-4907

2023

Volltextzugriff (PDF)

Longitudinal changes of tau PET imaging in relation to hypometabolism in prodromal and Alzheimer's disease dementia

Molecular psychiatry, 2018-07, Vol.23 (7), p.1666-1673

2018

Volltextzugriff (PDF)

Tracer Kinetic Analysis of (S)-¹⁸F-THK5117 as a PET Tracer for Assessing Tau Pathology

The Journal of nuclear medicine (1978), 2016-04, Vol.57 (4), p.574-581

2016

Volltextzugriff (PDF)

Imaging in-vivo tau pathology in Alzheimer’s disease with THK5317 PET in a multimodal paradigm

European journal of nuclear medicine and molecular imaging, 2016-08, Vol.43 (9), p.1686-1699

2016

Volltextzugriff (PDF)

Dual tracer tau PET imaging reveals different molecular targets for 11C-THK5351 and 11C-PBB3 in the Alzheimer brain

European journal of nuclear medicine and molecular imaging, 2018-07, Vol.45 (9), p.1605-1617

2018

Volltextzugriff (PDF)

Pittsburgh compound B imaging and cerebrospinal fluid amyloid-β in a multicentre European memory clinic study

Brain (London, England : 1878), 2016-09, Vol.139 (Pt 9), p.2540-2553

2016

Volltextzugriff (PDF)

Correction to: The Strategic Biomarker Roadmap for the validation of Alzheimer’s diagnostic biomarkers: methodological update

European journal of nuclear medicine and molecular imaging, 2021-12, Vol.48 (13), p.4525-4531

2021

Volltextzugriff (PDF)

Astrocyte Signature in Alzheimer's Disease Continuum through a Multi-PET Tracer Imaging Perspective

Cells (Basel, Switzerland), 2023-05, Vol.12 (11), p.1469

2023

Volltextzugriff (PDF)

Assessment of Tau Pathology as Measured by 18F-THK5317 and 18F-Flortaucipir PET and Their Relation to Brain Atrophy and Cognition in Alzheimer's Disease

Journal of Alzheimer's disease, 2021-01, Vol.84 (1), p.103

2021

Volltextzugriff (PDF)

Imaging Neuroinflammation: Quantification of Astrocytosis in a Multitracer PET Approach

Methods in molecular biology (Clifton, N.J.), 2024, Vol.2785, p.195

2024

Volltextzugriff (PDF)

1 – 25 von 49

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(45)
Mit Volltextzugriff
(45)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(30)
Life Sciences & Biomedicine
(28)
Medicin Och Hälsovetenskap
(26)
Humans
(21)
Alzheimer's Disease
(15)
Neurosciences & Neurology
(13)
Aged
(12)
Male
(12)
Female
(11)
Neurosciences
(11)
Alzheimer Disease - Diagnostic Imaging
(10)
Middle Aged
(10)
Biomarkers
(9)
Positron Emission Tomography
(9)
Clinical Neurology
(7)
Positron-Emission Tomography - Methods
(7)
Adult
(6)
Alzheimer Disease - Metabolism
(6)
Alzheimer’s Disease
(6)
Medicine
(6)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Detection rates and phenotypic spectrum of m.3243A>G in the MT-TL1 gene: a molecular diagnostic laboratory perspective

A Molecular Framework for the Phylogeny of the Ant Subfamily Dolichoderinae

Molecular Evidence for a Jurassic Origin of Ants

Functional respiratory chain analyses in murid xenomitochondrial cybrids expose coevolutionary constraints of cytochrome b and nuclear subunits of complex III

Role of Anthropometric Characteristics in Idiopathic Carpal Tunnel Syndrome

P.P.6 04 The clinical and molecular characterisation of calpain deficiency in patients with neuromuscular disorders

Alzheimer's disease profiled by fluid and imaging markers: tau PET best predicts cognitive decline

Diverging longitudinal changes in astrocytosis and amyloid PET in autosomal dominant Alzheimer's disease

Longitudinal changes of tau PET imaging in relation to hypometabolism in prodromal and Alzheimer’s disease dementia

The strategic biomarker roadmap for the validation of Alzheimer’s diagnostic biomarkers: methodological update

Profiling of plasma biomarkers in the context of memory assessment in a tertiary memory clinic

Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers

Clinical validity of increased cortical uptake of amyloid ligands on PET as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework

Comparison of Early-Phase 11C-Deuterium-l-Deprenyl and 11C-Pittsburgh Compound B PET for Assessing Brain Perfusion in Alzheimer Disease

Clinical validity of increased cortical binding of tau ligands of the THK family and PBB3 on PET as biomarkers for Alzheimer’s disease in the context of a structured 5-phase development framework

Blood β-synuclein is related to amyloid PET positivity in memory clinic patients

Longitudinal changes of tau PET imaging in relation to hypometabolism in prodromal and Alzheimer's disease dementia

Tracer Kinetic Analysis of (S)-¹⁸F-THK5117 as a PET Tracer for Assessing Tau Pathology

Imaging in-vivo tau pathology in Alzheimer’s disease with THK5317 PET in a multimodal paradigm

Dual tracer tau PET imaging reveals different molecular targets for 11C-THK5351 and 11C-PBB3 in the Alzheimer brain

Pittsburgh compound B imaging and cerebrospinal fluid amyloid-β in a multicentre European memory clinic study

Correction to: The Strategic Biomarker Roadmap for the validation of Alzheimer’s diagnostic biomarkers: methodological update

Astrocyte Signature in Alzheimer's Disease Continuum through a Multi-PET Tracer Imaging Perspective

Assessment of Tau Pathology as Measured by 18F-THK5317 and 18F-Flortaucipir PET and Their Relation to Brain Atrophy and Cognition in Alzheimer's Disease

Imaging Neuroinflammation: Quantification of Astrocytosis in a Multitracer PET Approach

Suchergebnisse filtern